Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even if President Donald Trump imposes high tariffs because they are "highly competitive",

With tariffs on imports averaging 14%, India is especially vulnerable to the reciprocal levies Trump says he will impose on some countries.

India Prime Minister Narendra Modi wants to talk about much more than tariffs as he visits the White House today.

Indian drugmakers are hoping that bilateral discussions between the country and the United States will help them steer clear of President Donald Trump's plan to levy at least 25% tariffs on pharmaceutical imports,

President Donald Trump has announced a sweeping 25% tariff on auto imports, semiconductors, and pharmaceuticals, set to take effect as early as April 2. He warned that these tariffs could go even higher within a year,